Last Posted: Sep 04, 2020
- Metabolic Serendipities of Expanded Newborn Screening.
Yahyaoui Raquel et al. Genes 2020 Aug 11(9) - Vulnerable Child Syndrome and Newborn Screening Carrier Results for Cystic Fibrosis or Sickle Cell.
Farrell Michael H et al. The Journal of pediatrics 2020 Sep 22444-50.e1 - Health-care practitioners’ preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment
S Jiang et al, Genetics in Medicine, AUgust 21, 2020 - Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes.
Kuo Chieh-Wen et al. Molecular genetics & genomic medicine 2020 Aug e1455 - Participant choices for return of genomic results in the eMERGE Network
C Howell et al, Genetics in Medicine, July 16 2020 - Differences in Conceptual Understanding of the "Actionability" of Incidental Findings and the Resultant Difference in Ethical Responsibility: An Empirical Study in Japan.
Ibuki Tomohide et al. AJOB empirical bioethics 2020 Jul 1-8 - Frequency of genomic secondary findings among 21,915 eMERGE network participants
Emerge Working Group, Genetics in Medicine, June 17, 2020 - Whole-Exome Sequencing-Based Approach for Germline Mutations in Patients with Inborn Errors of Immunity.
Okano Tsubasa et al. Journal of clinical immunology 2020 Jun - A structural variation reference for medical and population genetics.
Collins Ryan L et al. Nature 2020 May 581(7809) 444-451 - Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on endocrine hypertension of the European society of hypertension.
Lenders Jacques W M et al. Journal of hypertension 2020 May
No hay comentarios:
Publicar un comentario